Review

The role of GLP-1 receptor agonists in managing type 2 diabetes

Noura Nachawi, MD, Pratibha PR Rao, MD, MPH and Vinni Makin, MBBS, MD, FACE
Cleveland Clinic Journal of Medicine August 2022, 89 (8) 457-464; DOI: https://doi.org/10.3949/ccjm.89a.21110

Article Information

vol. 89 no. 8 457-464
DOI 
https://doi.org/10.3949/ccjm.89a.21110
PubMed 
35914933
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online August 1, 2022.
Copyright & Usage 
Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Noura Nachawi, MD
  1. Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH
  1. Pratibha PR Rao, MD, MPH
  1. Quality Improvement Officer, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Vinni Makin, MBBS, MD, FACE⇑
  1. Director, East Region, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic; Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Address:
    Vinni Makin, MBBS, MD, FACE, Department of Endocrinology, Diabetes, and Metabolism, F20, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; makinv{at}ccf.org
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects